Replies to post #744369 on NorthWest Biotherapeutics Inc (NWBO)

[manibiotech]

Completely agree 
That's is true for whole management 

[dennisdave]

But big megaphones won’t matter if they don’t fill in the blanks. They must name product collaborators, products and terms of licensing (as licensors and as licensees), name parties in contracts they state they’ve already signed (and any they are about to sign), IND status, Flaskworks progress, Direct progress, any and all planned or consummated nondilutive funding, status of NICE application and if CDF funding attempted and what transpired. Either these guys have been on crack or they’ve been cracking the whip behind the scenes. We need massive transparency upon any approval. The patience and understanding about the details trickle due to regulatory review will, imo, end upon any approval.

100% agree

[HappyLibrarian]

Either these guys have been on crack or they’ve been cracking the whip behind the scenes. We need massive transparency upon any approval. The patience and understanding about the details trickle due to regulatory review will, imo, end upon any approval.

I cannot argue with that or your other points.

I hope that they will do and at this point have done the things we need for them to do.

What I dread is that they will somehow try to move the goalposts to NICE reimbursement approval or even FDA approval. Like you I believe that they kicked the can down the road so many times it’s flat, but who knows, maybe they could get away with one more kick. I never thought they could manage it this many times or for this many years.